Skip to content

    Epigral Limited

    Gujarat-based chlor-alkali and derivative chemicals maker, running one fully integrated complex at Dahej.

    Chemicals
    Commodities
    View EPIGRAL earnings calls
    ₹1,127.6
    -4.82% from avg

    Overview

    Price

    ₹1,127.6

    Market Cap

    ₹5.0k Cr

    Sector

    Chemicals

    Commodities

    Rank

    3

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY20FY21FY22FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital4242424242434343
    Reserves3314326841.0k1.2k1.9k2.1k2.2k
    Borrowings737753993879964593537572
    Other Liabilities164223405484576655598712
    Total Liabilities1.3k1.4k2.1k2.4k2.8k3.2k3.2k3.5k
    AssetsFixed Assets4401.1k1.1k1.8k1.8k2.2k2.2k2.1k
    CWIP69112658915848364309451
    Investments0002121974423
    Other Assets142221467449524752707915
    Total Assets1.3k1.4k2.1k2.4k2.8k3.2k3.2k3.5k

    Valuation

    Assumptions

    Current — EPIGRAL
    Price
    ₹1,128
    EPS (TTM)
    ₹62.99
    PE (TTM)
    17.9
    Profit growth
    -2.6%

    The Earnings Per Share over the last 12 months.

    %

    Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).

    Pre-filled with the lower of median (18.4×) and current (17.9×) PE — the conservative anchor.

    %

    The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.

    Valuation

    Current price
    ₹1,128
    vs
    Fair value · 15% return
    ₹403
    64%Overvalued

    At -2.6% growth and a 18× exit, ₹1128 only delivers your return if you pay ₹403. The price is currently baking in 17% growth.

    EPS grows -2.6%/yr for 5 years, then fades to 6% over 2, exits at 18×.

    YearGrowthEPS (₹)
    FY27-2.6%61.35
    FY28-2.6%59.76
    FY29-2.6%58.20
    FY30-2.6%56.69
    FY31-2.6%55.22
    FY321.7% ·fade56.15
    FY336.0% ·fade59.52

    Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.

    Learn to analyse Epigral Limited

    Guides on how to read this kind of business and the numbers that matter.